Symbol="CFRX"
AssetType="Common Stock"
Name="ContraFect Corp"
Description="ContraFect Corporation, a clinical-stage biotechnology company, focuses on the discovery and development of protein and antibody therapeutics for the treatment of drug-resistant and life-threatening infectious diseases in the United States. The company is headquartered in Yonkers, New York."
CIK="1478069"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="28 WELLS AVENUE, 3RD FLOOR, YONKERS, NY, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="3413000"
EBITDA="-49612000"
PERatio="None"
PEGRatio="0"
BookValue="-2.003"
DividendPerShare="0"
DividendYield="0"
EPS="-868.07"
RevenuePerShareTTM="0"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="-0.812"
ReturnOnEquityTTM="-3.452"
RevenueTTM="0"
GrossProfitTTM="-1606434"
DilutedEPSTTM="-868.07"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0"
AnalystTargetPrice="5"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="-"
PriceToBookRatio="0.441"
EVToRevenue="-"
EVToEBITDA="0.163"
Beta="0.462"
num_52WeekHigh="26.95"
num_52WeekLow="0.9"
num_50DayMovingAverage="1.387"
num_200DayMovingAverage="4.721"
SharesOutstanding="3669900"
DividendDate="2020-02-04"
ExDividendDate="None"
symbol="CFRX"
open="1.00"
high="1.00"
low="0.91"
price="0.96"
volume="59911.00"
latest_trading_day="2023-08-14"
previous_close="0.97"
change="-0.01"
change_percent="-1.0412%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="66"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Trending High"
value_analysis="Bullish Trend"
Aroon_change="FALSE"
Aroon_momentum="34"
Volume_recent_avg="2658818"
Change_recent_avg="-0.04"
Delta_recent_avg="0.2"
Variance_recent_avg="0.1"
Change_ratio_recent_avg="-2.86"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="34"
Aroon_momentum_negative="66"
image_negative_thumbnail_id_1="519"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0086.jpeg"
image_negative_thumbnail_id_2="1123"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0156.jpeg"
image_neutral_thumbnail_id_1="581"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0018.jpeg"
image_neutral_thumbnail_id_2="569"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0030.jpeg"
image_positive_thumbnail_id_1="665"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0043.jpeg"
image_positive_thumbnail_id_2="648"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0060.jpeg"
image_professor_thumbnail_id_1="1176"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
image_professor_thumbnail_id_2="1192"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0026.jpeg"
